Harold H. Shlevin

CIK 1557082 · Chief Executive Officer · last filed 2026-01-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$17.4K

Companies

2

Total Filings

28

Lifetime Open-Market Net

-$3.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GALT Director 6,500 $2.67 $17.4K -$3.68M 20 2026-01-21
GALECTIN THERAPEUTICS INC (GALTW) Delisted Chief Operating Officer 103,914 $3.3K 8 2016-12-06

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-12-06 GALECTIN THERAPEUTICS INC (GALTW) Delisted Grant (A) $0 EDGAR
2016-01-22 GALECTIN THERAPEUTICS INC (GALTW) Delisted Grant (A) $0 EDGAR
2015-02-02 GALECTIN THERAPEUTICS INC (GALTW) Delisted Grant (A) $0 EDGAR
2014-01-24 GALECTIN THERAPEUTICS INC (GALTW) Delisted Grant (A) $0 EDGAR
2014-01-13 GALECTIN THERAPEUTICS INC (GALTW) Delisted Mixed +41,402 $4 EDGAR
2013-11-19 GALECTIN THERAPEUTICS INC (GALTW) Delisted Buy (P) +500 $3.3K EDGAR
2013-05-01 GALECTIN THERAPEUTICS INC (GALTW) Delisted Mixed +53,414 $2 EDGAR
2012-08-29 GALECTIN THERAPEUTICS INC (GALTW) Delisted Grant (A) $0 EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.